globalbarry. Company Intelligence Engine

Coherus Oncology, Inc.

CHRS CIK 0001512762 · Biological Products, (No Diagnostic Substances) (SIC 2836)

Disclosed SEC business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065

Coherus Oncology, Inc. (ticker CHRS, CIK 0001512762) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

456 exposure relationships mapped 75 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
  • FACT Country of disclosed business address: United States
  • FACT 8-K filed (period 2026-08-28) 2026-08-28 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.